Vivek Ramaswamy
Just before Christmas last year, a newly formed Bermuda-based biotech run by former hedge fund partner Vivek Ramaswamy struck a deal to in-license a shelved Alzheimer’s drug from GlaxoSmithKline ($GSK) with plans to put it into Phase III. That late-stage study won’t start until the fourth quarter, but the newborn biotech isn’t waiting around at the starting line. The […]
NASDAQ had a good surge last week, but now people are honestly wondering what’s next. It had a nice pop at the open yesterday,, but immediately headed south and stayed there for the rest of the session. The bad news was that there was no enthusiasm for buying, but the good news was that there was no real selling after […]
Benchmarks ended higher on Tuesday boosted by better-than-expected corporate results. Comcast, Harley-Davidson, Netflix, Travelers and United Tech posted upbeat quarterly earnings. New deals in the health care sector also contributed to the bullish sentiment. A modest fall in existing home sales data in March hardly impacted the benchmarks.For a look at the issues currently facing the markets, make sure to […]
